drugset / Trial / NCT06921616

Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Lobar Intracerebral Hemorrhage at the Early Stage.

NCT06921616

Phase 4 Not yet recruiting 396 enrolled Yong Jiang
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this trial is to investigate whether neuroendoscopic hematoma evacuation combined with early use of methylprednisolone sodium succinate can improve the efficacy and safety in the treatment with that of simple neuroendoscopic surgery alone for patients with spontaneous lobar intracerebral hemorrhage within 24 hours after the onset.

Timeline

Start
2025-05-01
Primary completion
2026-11-30
Completion
2027-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 2 mg/kg Intravenous